Top

Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread

February 22, 2010 by admin · Leave a Comment 

Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic Read more

Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer

February 15, 2010 by admin · Leave a Comment 

Contact: Sandra Shagat
sshagat@dentistry.ucla.edu
310-206-0835
University of California - Los Angeles Read more

Researchers find drug that reverses resistance to chemotherapy for Pancreatic cancer

September 24, 2009 by admin · 1 Comment 

For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

Read more

MicroRNAs circulating in blood show promise as biomarkers to detect pancreatic cancer

September 7, 2009 by admin · Leave a Comment 

A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, researchers at The University of Texas M. D. Anderson Cancer Center report in the September edition of the journal Cancer Prevention Research.

Read more

Prion protein identified as a novel early pancreatic cancer biomarker

August 18, 2009 by admin · Leave a Comment 

Case Western Reserve researchers follow the prion’s path from mad cow disease to deadly cancer

Mad cow disease is caused by the accumulation of an abnormal protein, the prion, in the brain of an affected patient. Outside of the brain, very little is known about prions. Case Western Reserve University School of Medicine, researchers have, for the first time, identified the prion as a biomarker for pancreatic cancer. Pancreatic cancer is one of the most deadly cancers in humans; the five year survival rate is less than 10 percent.

Read more

Herbal extract proven to inhibit the development of pancreatic cancer

April 19, 2009 by admin · Leave a Comment 

An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #494)

Read more

Pfizer Stops Sutent Trial Early, Citing Benefit For Rare Form of Pancreatic Cancer

March 12, 2009 by admin · Leave a Comment 

Pfizer Inc. (PFE) said Thursday it stopped a late-stage trial of its drug Sutent early because the drug showed “significant benefit” in patients with a rare form of pancreatic cancer.

The finding is another positive for Sutent, which last month was backed for use in kidney cancer by the U.K. agency that decides which treatments are made available in the publicly funded health-care system in England and Wales, reversing an earlier recommendation. The agency still rejected several other companies’ drugs for kidney cancer. Sutent is approved in the U.S. to treat kidney cancer and a digestive-tract cancer.

Read more

Pancreatic tumor growth in mice by inhibiting key protein

February 1, 2009 by admin · Leave a Comment 

Researchers at Stanford University School of Medicine have identified a protein critical for the growth of pancreatic cancer. Blocking the expression of the protein slowed or prevented tumor growth in mice and made cultured cancer cells vulnerable to the conditions of low oxygen that occur in solid tumors.

Read more

New Cancer Treatment Shrinks Pancreatic Tumor

November 24, 2008 by admin · Leave a Comment 

NASHVILLE, Tenn., Nov. 24 — A new cancer treatment is realizing outstanding results against pancreatic cancer. Following five weeks of treatment, a patient’s large, stage 4 tumor was reduced in size by 70%. After seven more weeks of treatment, it no longer could be definitely identified on scans. Pancreatic cancer usually is fatal six to nine months after diagnosis. NeoPlas Innovation’s combination of FDA-approved drugs appears to improve those odds for some patients, based on this result and similar ones seen before the protocol’s public availability.

Read more

New treatment combination safe for pancreatic cancer patients

June 2, 2008 by admin · Leave a Comment 

Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Read more

Next Page »

Bottom